Newsroom

Takeda Corporate Information

To learn about our parent company, Takeda Pharmaceutical Company Limited, please visit http://www.takeda.com/

Media Inquiries

For media inquiries or reporter requests for more information, contact our Corporate Communications via Media_Relations@takeda.com. If you generally would like to contact us, please visit Contact Us.

Recent News Releases

September 28, 2021 9/28/2021

Seramount Names Takeda as One of the 2021 100 Best Companies and Best Companies for Dads

June 14, 2021 6/14/2021

U.S. Food and Drug Administration Accepts Takeda’s Supplemental Biologics License Application for Adult Prophylactic Use of VONVENDI® [von Willebrand factor (Recombinant)]

March 1, 2021 3/1/2021

The Children’s National Hospital Rare Disease Institute and Takeda Partner to Standardize Care for Patients With Rare Diseases

December 15, 2020 12/15/2020

U.S. Food and Drug Administration Accepts New Drug Application for Review, Grants Priority Review for Takeda’s
TAK-721 (budesonide oral suspension) for the Treatment of Eosinophilic Esophagitis

December 2, 2020 12/2/2020

TAKEDA FURTHER ENABLES HEMOPHILIA A PERSONALIZED CARE WITH LAUNCH OF MYPKFIT® SOFTWARE FOR ADYNOVATE ® [ANTIHEMOPHILIC FACTOR (RECOMBINANT), PEGYLATED]

SEE ALL NEWS AND RELEASES >